Wednesday 21st November 2018
|Text too small?|
Trade Me Group says British private equity firm Apax Partners has approached it with a non-binding indicative offer to take it over for $6.40 per share.
That’s a 25.5 percent premium to Tuesday’s close at $5.10 and values Trade Me at $2.54 billion. The shares are now trading at $6.09, up 99 cents, or 19.4 percent.
“This indicative proposal is subject to a number of conditions, including the completion of due diligence,” the online market place says in a statement.
“The board of Trade Me, together with its advisers, has reviewed the indicative proposal and has decided to engage with Apax,” it says.
Goldman Sachs is advising the company.
“Trade Me has provided Apax with due diligence access on an exclusive basis until Dec. 12 to facilitate a binding offer. This exclusive access is subject to a ‘fiduciary carve-out’ that permits Trade Me to engage with third parties, should it receive any unsolicited proposals.”
The directors say there is no certainty the indicative proposal will result in an offer or any other transaction for Trade Me. Shareholders need take no action in the meantime “and they should not do so without assessing all available information and seeking their own professional advice.”
Other Apax investments include Israel-based Global-e Online, which provides cross-border e-commerce solutions, Genius Sports, a British-based sports data company, SoYoung, the largest online marketplace for aesthetic medical treatments in China, MatchesFashion.com, a British-based predominantly online global luxury goods retailer, and Moda Operandi, a British-based online luxury fashion retailer.
No comments yet
NZ dollar benefits from dovish Fed, domestic growth
Fisher Funds backs Infratil's Vodafone play
Ballance partners with Hiringa for Kapuni hydrogen project
Kiwi Property eyes residential development for mixed-use centres
Strong construction growth shores up 1Q GDP but services weak
Sharesies to offer fractionalised NZX shares
20th June 2019 Morning Report
NZ dollar steady ahead of Fed decision, NZ GDP
Vital proceeds with $37m first stage of Wakefield Hospital redevelopment
Risks from exploration ban coming to pass